Departments of *Psychological and Brain Sciences
#Psychiatry, Washington University in St. Louis
‡Knight Alzheimer Disease Research Center
§Hope Center for Neurological Disorders, St. Louis, MO
Funding for this study was provided by the National Institute on Aging R01AG043434, P50AG005681, P01AG003991, P01AG026276; UL1TR000448; P30NS098577; R01EB009352; the Barnes-Jewish Hospital Foundation, and the Charles and Joanne Knight Alzheimer Research Initiative of the Washington University Knight Alzheimer Disease Research Center (ADRC). A.M.F. is supported by NIH grants including P50AG005681, P01AG003991, P01AG026276, and UF01AG03243807. J.C.M. is funded by NIH grants # P50AG005681; P01AG003991; P01AG026276 and UF1AG032438. T.L.B. is funded by NIH grants P01AG003991, P01AG003991, P01AG026276, P50AG005681, UF1AG032438, U01AG042791, RF1AG053550, R01NS095773, R01AG056466, R01AG053548, R01AG053503, R01AG057536, R01AG052550, R01AG046179, P01AG052350, R01AG053267, U01AG059798, and R56AG061900. J.H. is funded by NIH grants including R01AG057840; P50AG005681; P01AG003991; P01AG026276, and UF1AG032438. C.C. is funded by NIH# R01AG044546, P01AG003991, RF1AG053303, RF1AG058501, and U01AG058922.
A.M.F. is on the Scientific Advisory Boards for Roche Diagnostics, AbbVie and Genentech and consults for Araclon Biotech/Griffols, Biogen, and DiamiR. T.L.B. is an investigator in clinical trials sponsored by Avid Radiopharmaceuticals, Eli Lilly, Roche, and Biogen. J.H. serves on scientific advisory boards for Lundbeck, Biogen, and Takeda and serves on a Data Safety and Monitoring Board for Eisai. C.C. receives research support from Biogen, EISAI, Alector and Parabon, and is a member of the advisory board of ADx Healthcare, Halia Terapeutics, and Vivid Genomics. The remaining authors declares no conflicts of interest.
Reprints: Denise Head, PhD, Department of Psychological and Brain Sciences, Washington University in St. Louis, One Brookings Drive, P.O. Box 1125, St. Louis, MO 63130 (e-mail: [email protected]).